Financial Comparison Highlights Valuation and Risk Differences Between Addex Therapeutics…
What happened
A comparison of Addex Therapeutics and Bayer Aktiengesellschaft was published, contrasting the two healthcare companies across several financial metrics. The analysis noted that Addex Therapeutics has lower revenue but higher earnings than Bayer Aktiengesellschaft. Bayer Aktiengesellschaft is trading at a lower price-to-earnings ratio than Addex Therapeutics, suggesting it is currently more affordable.
From dailypolitical.com
Why it matters
The comparison highlights significant differences in risk and valuation between the two firms. Bayer Aktiengesellschaft has a beta of 0.56, indicating lower volatility compared to Addex Therapeutics, which has a beta of 1.47. The findings provide insight into relative investment profiles for both companies.
From dailypolitical.com
Who's involved
- Addex TherapeuticsSwiss public company whose financial metrics and ownership structure were analyzed
Who could feel it
Possible knock-on effectsThese are possibilities Brind reasoned out, not predictions, and not advice. Most are not stated in any report.
- Addex TherapeuticsSpeculative
Investors might adjust their investment decisions based on the reported differences in valuation and volatility.
Keep exploring
The entities involved
-
Addex Therapeutics
Swiss public company